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EDITORS’ PICKSFungus among us
Candida albicans is a common pathogen at barrier sites
under immunosuppressed conditions. In order to more clearly
elucidate the cell types and cytokine networks involved
in resistance to such infection in the skin, Kashem and
colleagues employed an epicutaneous C. albicans infection
murine model that does not require immunosuppression for
infection. These studies revealed that resistance requires
interleukin (IL)-17A produced by gd T cells. In addition, IL-23
derived from CD301þ dermal dendritic cells was required for
this IL-17A production. Most interestingly, these investigators
demonstrated that sensory neurons directly respond to
C. albicans, resulting in efﬁcient clearance of the pathogen via
a mechanism mediated by the neuropeptide calcitonin gene-
related peptide (CGRP). These results highlight complex
events that link sensory neurons, dendritic cells, and gd T cells
in the efﬁcient response to a fungal pathogen at the epidermal
barrier. (Immunity 43:515-526, 2015) Selected by N. Ward
Atopic epidemic
Although great strides have been made in unearthing genetic
mutations and disease processes in atopic dermatitis (AD),
the basis for the sudden and dramatic increase in atopic
disease in general over the last 50 years remains a mystery.
Mechanisms, including the hygiene hypothesis, natural TH2
skewing during pregnancy and early life confounded by
environmental exposure to chemical allergens, and the
underlying primary abnormality in barrier function, have
garnered support. Thyssen and colleagues recently penned a
perspective analysis in support of a role of reduced environ-
mental UV exposure as the driver of this current atopic
epidemic. Citing studies documenting the potential beneﬁts
of blue-light therapy in premature neonates as well as UVB
irradiation-induced improvement of skin barrier function,
reduction of S. aureus colonization, reduced pruritus, and
increased sun-induced vitamin D production, these in-
vestigators suggest that decreased solar radiation exposure
may explain the increased prevalence of AD in urban
children. Ultimately, this intriguing hypothesis offers a
unique, but not exclusive, partial explanation of factors
that inﬂuence AD prevalence. (J Allergy Clin Immunol
136:1163e1169, 2015) Selected by H. Williams
New insight from the chemical barrier
Despite continuous exposure to microorganisms, the skin is
rarely infected thanks to the presence of the stratum corneum
as well as the presence of a chemical barrier of antimicrobial
peptides and proteins. Pseudomonas aeruginosa causes severe
infections especially in cystic ﬁbrosis patients and burn vic-
tims, and the emerging antibiotic resistance of these organisms
demands development of novel effective drugs. Hansmann
and colleagues demonstrated that the water-insoluble ﬁlag-
grin-2 (FLG2) is present in stratum corneum, especially in
palmar and plantar skin, a location proximal to soil- andwater-Journal of Investigative Dermatology (2016) 136, 3. doi:10.1016/
j.jid.2015.11.021
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with P. aeruginosa, C-terminal FLG2 fragments are generated
upon breakdown of the stratum corneum components by the
bacteria, resulting in membrane blebbing of the bacteria.
These fragments exhibit antimicrobial activity toward
P. aeruginosa via interference with the bacterial replication
machinery, leading to bacterial death. These exciting ﬁndings
highlight the potential of FLG2 C-terminal fragments as novel
antimicrobials for the eradication of P. aeruginosa infection,
which especially threatens cystic ﬁbrosis patients. (PLoS
Pathog 11:e1005159, 2015) Selected by T. SchwarzFighting fungal infections
Fungal infections are particularly problematic for immuno-
compromised populations; yet, despite constant exposure and
colonization of body surfaces with fungi, healthy individuals
remain remarkably unscathed. While antimicrobial peptides
are the main candidate effector molecules, our understanding
of these fungal defense strategies is relatively limited. Hein and
colleagues recently identiﬁed disulphide-reduced psoriasin
(redS100A7) as a primary antifungal agent on human body
surfaces. Additional analyses revealed that redS100A7 is a
broad-spectrum antifungal that induces apoptosis-like cell
death in fungi in a zinc-dependent manner. In addition,
redS100A7 alongwith another cell-penetrating, zinc-chelating
fungal agent, TPEN (N,N,N’,N’-tetrakis[2-pyridylmethyl]-
ethylenediamine), prevented infection following dermato-
phyte infection in a guinea pig tinea pedes model and
prevented death from invasive fungal infection following
infection of immunocompromised mice with a lethal dose of
Aspergillus. This discovery suggests that fungus-penetrating,
zinc-chelating antifungal agents may be important novel ther-
apeutics for opportunistic or invasive fungal infections. (PNAS
112:13039-13044, 2015) Selected by T. SchwarzInto the sunlight
Erythropoietic protoporphyria is a devastating photo-
dermatosis characterized by acute phototoxicity, severe pain,
and a decreased quality of life as a result of accumulated
protoporphyrin in erythroid cells and tissues in the absence
of effective treatments. In a phase 3, multicenter, randomized,
double-blind, placebo-controlled trial involving 167 patients
in both the European Union and the United States,
Langendonk and colleagues demonstrated that afamelano-
tide (Scenesse, Clinuvel Pharmaceuticals), a potent a-mela-
nocyte-stimulating hormone analog, was safe and effective
for treating photosensitivity in patients with erythropoietic
protoporphyria. Signiﬁcant improvements in duration of
pain-free sun exposure time, severity of phototoxic reactions,
and recovery time were observed in patients treated with
afamelanotide. Furthermore, a favorable effect on patient
quality of life was detected following treatment. Thus,
afamelanotide-induced eumelanin synthesis may offer anti-
oxidant defense in melanocytes, neutralizing the effects of
sunlight and allowing more direct exposure to sunlight
without pain in these patients. (N Engl J Med 373:48-59,
2015) Selected by T. Schwarzwww.jidonline.org 3
